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Abstract
Probiotics have been found to be beneficial to host health. Their primary use in medicine has been for the manage-
ment of intestinal tract problems.
In recent years, probiotics have been used as a treatment to promote oral health. The aim of the present study was 
to review published studies regarding probiotics and their effects on the oral cavity. Studies reporting the anticar-
iogenic effects of probiotics, their use in the treatment of periodontal disease, a reduced crevicular fluid volume 
and cytokine content, as well as their use in the treatment of halitosis and Candida albicans were identified. Stud-
ies assessing residence time of probiotics in the oral cavity were also selected for retrieval. Most authors concluded 
that the use of oral probiotics was associated with an improvement in oral health, including a significantly reduced 
level of cariogenic and periodontal pathogens and a lower crevicular fluid volume and cytokine concentration.
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Introduction
Probiotics were defined by FAO/WHO (The Food Ag-
ricultural Organization/World Health Organization) as 
live microorganisms which when administered in ad-
equate amounts (in food or as a dietary supplement) 
confer a health benefit on the host (improving micro-
biological balance in intestinal tract) (1,2). Such non-
pathogenic organisms (yeasts or bacteria, particularly 
lactic acid bacteria) are present in food, and can have 
a favorable impact on host health. Probiotics have bee 
used for decades in fermented products, but potential 
use of probiotics as a nutritional medical therapy has not 
been formally acknowledged (2). 
Metchnikoff was the first to state that probiotics could 
provide a health benefit, and proposed that Bulgarian 
people had a longer longevity due to fermented milk 
containing viable bacteria. “Probiotic” term, as op-
posed to “antibiotic”, was initially proposed by Lilley 
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and Stillwell in 1965. First probiotic species to be in-
troduced in research was Lactobacillus acidophilus by 
Hull et al. in 1984; followed by Bifidobacterium bifidum 
by Holcombh et al. in 1991 (3).
Probiotics can improve patient condition in medical dis-
orders such as diarrhea, gastroenteritis, short-bowel syn-
drome, and inflammatory intestinal diseases (Crohn’s 
disease and ulcerative colitis), cancer, immunodepres-
sive states, inadequate lactase digestion, pediatric aller-
gies, growth retardation, hyperlipidemia, liver diseases, 
infections with Helicobacter pylori, genitourinary tract 
infections, and others; all such findings have been sup-
ported by several studies demonstrating improved re-
sults after using probiotics (2-4).
Currently available information on oral probiotic uses, 
such as therapy for oral cavity disorders including tooth 
decay or periodontal disease, is scarce. The aim of the 
present study was to update such information based on 
studies assessing probiotics effects in oral cavity. A 
literature search in Pub-Med database was performed 
for English- or Spanish-language articles, using the fol-
lowing search terms: “probiotics” and “oral health”; no 
restrictions were used for publication dates.
Mechanism of action of probiotics in oral cavity
In oral cavity, probiotics can create a biofilm, acting as 
a protective lining for oral tissues against oral diseases. 
Such a biofilm keeps bacterial pathogens off oral tissues 
by filling a space pathogens would invade in the absence 
of the biofilm (4); and competing with cariogenic bacte-
ria and periodontal pathogens growth (5).
Probiotics and cariogenic pathogens
Probiotics can reduce the risk for a high Streptococ-
cus mutans level occurrence (6-8). An in vitro study 
has suggested Lactobacillus rhamnosus GG can inhibit 
colonization by streptococcal cariogenic pathogens, and 
therefore reduce tooth decay incidence in children (7). 
Näse et al. (6) reported a reduced tooth decay incidence 
in children taking probiotic L. rhamnosus GG-enriched 
milk versus a control group of children taking milk 
without probiotic enrichment. Similar findings were ob-
served by Ahola et al. (7) after administering the same 
probiotic. Nikawa et al. (8) showed that bovine milk fer-
mented with Lactobacillus reuteri was effective against 
S. mutans, resulting in a reduced risk for tooth decay.
Unlike Meurman et al. (9) and Nikawa et al. (8), Mon-
talto et al. (10) reported an increased amount of Lacto-
bacillus in saliva, with no reduction of  S. mutans level, 
when administering to their patients Lactobacillus in 
a fluid form or in capsules to assess systemic effects. 
Also, Çaglar et al. (11), in a comparative study of S. 
mutans reduction effects by several probiotic admin-
istration forms, showed a reduced S. mutans level in 
patients receiving fluid or tablet probiotic forms. In an-
other study by Çaglar et al. (12), S. mutans reduction 
effects were compared in subjects using probiotics-, 
xylitol-, or probiotics plus xylitol-enriched chewing 
gums, and a placebo control group; a reduced S. mu-
tans level was observed in subjects using probiotics- or 
xylitol-enriched chewing gum; no synergic effect was 
seen when combining both agents. In another study by 
Çaglar et al. (13) probiotics effects were assessed after 
administration in a pacifier including a tablet that was 
dissolved in mouth after a 10 to 12-minute suction; a re-
duced S. mutans level versus control group was found. 
Effects of an ice-cream containing Bifidobacterium lac-
tis on S. mutans and Lactobacillus level in saliva were 
assessed by Çaglar et al. (14); a significantly reduced 
level was observed for S. mutans, but not for Lactoba-
cillus. Effects of lactic strains used as probiotics in oral 
cavity were evaluated by Comelli et al. (5); Streptococ-
cus thermophilus and Lactococcus lactis strains were 
shown to reduce cariogenic bacteria levels (particularly 
Streptococcus sobrinus and also Streptococcus oralis, 
Actinomyces naeslundii, and Veillonella dispar).
Probiotics and periodontal disease
The effect of probiotics tablets on gingivitis and differ-
ent grades of periodontitis was studied by Grudianov et 
al. (15); probiotics treatment resulted in better microbi-
ota normalization than control group. Krasse et al. (16) 
showed a significantly reduced gingival index and bac-
terial plaque amount in patients treated with  L. reuteri 
than in a placebo group and concluded that this probiotic 
was effective to reduce gingivitis and bacterial plaque 
deposition in patients with moderate-to-severe gingivi-
tis. According to Koll-Klais et al. (17), high levels of 
Lactobacillus in microbiota caused an 82% and 65% 
inhibition in Porphyromonas gingivalis and Prevotella 
intermedia growth, respectively.
Twetman et al. (18) used L. reuteri-containing chew-
ing gum in 42 healthy patients and assessed its effects 
on crevicular fluid volume, cytokine (interleukin-1β, 
interleukin-6, interleukin-10, and TNF-α) levels, and 
bleeding on probing. Crevicular fluid volume, as well 
as TNF-α and interleukin-8 levels, and bleeding were 
significantly reduced.
Probiotics and halitosis
Regular use of probiotics can help to control halitosis. 
After taking Weissella cibaria, reduced levels of volatile 
sulfide components produced by Fusobacterium nucle-
atum were observed by Kang et al. (19); the effect could 
be due to hydrogen peroxide production by W. cibaria, 
causing F. nucleatum inhibition. Streptococcus saliva-
rius also suppress volatile sulfide effects, by competing 
for colonization areas with volatile sulfide-producing 
species (20).
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Probiotics and Candida albicans
C. albicans is a leading cause of infection in oral cavity; 
it is particularly common in the elderly and in immu-
nocompromised patients. Hatakka et al. (21) showed a 
reduced prevalence of C. albicans after taking probio-
tics in cheese containing L. rhamnosus GG and Propi-
onibacterium freudenreichii ssp. shermanii JS. Results 
obtained by Koll et al. (22) when assessing the effects of 
various  Lactobacillus strains in oral cavity were mark-
edly different; most strains suppressed growth of peri-
odontal pathogens, including Aggregatibacter actino-
mycetemcomitans (60 out of 67 tested strains); Porphy-
romona gingivalis (35 out of 42 strains), P. intermedia 
(26 out of 42 strains), and cariogenic S. mutans (37 out 
of 67 strains). No inhibition was found, however, for C. 
albicans growth.
Residence time of probiotics in oral cavity
Residence time of probiotics in oral cavity after treat-
ment withdrawal was studied by Çaglar et al. (11). A re-
duced S. mutans level was shown after a two-week use 
of a L. reuteri-enriched yogurt; effects were observed 
during use and for a few days after discontinuation. A 
loss of L. reuteri colonization was observed by Wolf 
et al. (23) two months after having discontinued pro-
biotic use. L. rhamnosus GG administration and oral 
cavity colonization was studied by Yli-Knuuttila et al. 
(24); the authors concluded that permanent colonization 
in oral cavity was unlikely (although possible in some 
cases) and suggested the probiotic to be used on a regu-
lar basis. Binding strength of 17 Lactobacillus strains 
and 7 bifidobacteria strains to saliva and oral mucous 
membrane was variable in different strains, according 
to a study by Haukioja et al. (25); such a strength vari-
ation caused an increased residence time of probiotic in 
oral cavity. Latency time of probiotic S. salivarius K12, 
4 tablets/day for 3 days, was assessed in several oral 
cavity areas in a 35-day follow-up, by Horz et al. (26); 
probiotic could be found on oral mucous membrane, 
tongue and in stimulated saliva for more than 3 weeks, 
with a gradually reduced S. salivarius K12 level being 
detected beginning 8 days after treatment withdrawal.
Comments
A literature review shows that oral probiotics use is 
associated to an improvement in oral health, which is 
mainly due to significantly reduced levels of cariogenic 
as well as periodontal pathogens; volume and cytokine 
levels are also reduced. Nevertheless, further studies 
will be needed to show probiotics efficacy to improve 
oral health.
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